25 XP   0   0   10

China National Accord Medicines Corp Ltd
Buy, Hold or Sell?

Let's analyse China National Accord Medicines Corp Ltd together

PenkeI guess you are interested in China National Accord Medicines Corp Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of China National Accord Medicines Corp Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about China National Accord Medicines Corp Ltd

I send you an email if I find something interesting about China National Accord Medicines Corp Ltd.

Quick analysis of China National Accord Medicines Corp Ltd (30 sec.)










What can you expect buying and holding a share of China National Accord Medicines Corp Ltd? (30 sec.)

How much money do you get?

How much money do you get?
¥0.23
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
¥37.69
Expected worth in 1 year
¥35.31
How sure are you?
97.5%

+ What do you gain per year?

Total Gains per Share
¥-0.75
Return On Investment
-2.1%

For what price can you sell your share?

Current Price per Share
¥35.22
Expected price per share
¥32.60 - ¥43.64
How sure are you?
50%

1. Valuation of China National Accord Medicines Corp Ltd (5 min.)




Live pricePrice per Share (EOD)

¥35.22

Intrinsic Value Per Share

¥65.01 - ¥240.78

Total Value Per Share

¥102.70 - ¥278.47

2. Growth of China National Accord Medicines Corp Ltd (5 min.)




Is China National Accord Medicines Corp Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$2.8b$2.5b$213.7m7.6%

How much money is China National Accord Medicines Corp Ltd making?

Current yearPrevious yearGrowGrow %
Making money$55.2m$51.3m$3.8m7.0%
Net Profit Margin2.1%2.0%--

How much money comes from the company's main activities?

3. Financial Health of China National Accord Medicines Corp Ltd (5 min.)




4. Comparing to competitors in the Medical Distribution industry (5 min.)




  Industry Rankings (Medical Distribution)  


Richest
#6 / 40

Most Revenue
#12 / 40

Most Profit
#12 / 40

What can you expect buying and holding a share of China National Accord Medicines Corp Ltd? (5 min.)

Welcome investor! China National Accord Medicines Corp Ltd's management wants to use your money to grow the business. In return you get a share of China National Accord Medicines Corp Ltd.

What can you expect buying and holding a share of China National Accord Medicines Corp Ltd?

First you should know what it really means to hold a share of China National Accord Medicines Corp Ltd. And how you can make/lose money.

Speculation

The Price per Share of China National Accord Medicines Corp Ltd is ¥35.22. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of China National Accord Medicines Corp Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in China National Accord Medicines Corp Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥37.69. Based on the TTM, the Book Value Change Per Share is ¥-0.60 per quarter. Based on the YOY, the Book Value Change Per Share is ¥0.73 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.41 per quarter.
Based on historical numbers we can estimate the returns while holding a share of China National Accord Medicines Corp Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.100.3%0.110.3%0.110.3%0.100.3%0.080.2%
Usd Book Value Change Per Share0.130.4%-0.08-0.2%0.100.3%0.060.2%0.110.3%
Usd Dividend Per Share0.000.0%0.060.2%0.060.2%0.050.1%0.040.1%
Usd Total Gains Per Share0.130.4%-0.03-0.1%0.160.5%0.110.3%0.160.4%
Usd Price Per Share4.01-5.13-4.37-5.43-6.82-
Price to Earnings Ratio9.85-12.04-10.91-14.06-22.99-
Price-to-Total Gains Ratio31.25-24.27-29.86-37.39-57.50-
Price to Book Ratio0.77-1.02-0.82-1.14-2.71-
Price-to-Total Gains Ratio31.25-24.27-29.86-37.39-57.50-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share4.867404
Number of shares205
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.060.05
Usd Book Value Change Per Share-0.080.06
Usd Total Gains Per Share-0.030.11
Gains per Quarter (205 shares)-5.2922.51
Gains per Year (205 shares)-21.1790.02
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
146-68-31395180
293-135-5278102170
3139-203-73117154260
4185-270-94155205350
5232-338-115194256440
6278-405-136233307530
7324-473-157272358620
8371-540-178311409710
9417-608-199350461800
10463-675-220388512890

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%40.00.00.0100.0%87.00.01.098.9%
Book Value Change Per Share3.01.00.075.0%11.01.00.091.7%19.01.00.095.0%39.01.00.097.5%83.05.00.094.3%
Dividend per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%40.00.00.0100.0%81.00.07.092.0%
Total Gains per Share3.01.00.075.0%11.01.00.091.7%19.01.00.095.0%39.01.00.097.5%85.03.00.096.6%

Fundamentals of China National Accord Medicines Corp Ltd

About China National Accord Medicines Corp Ltd

China National Accord Medicines Corporation Ltd. engages in the retail and distribution of pharmaceutical products in China and internationally. it offers drugs, medical equipment, cargo transportation, warehousing, loading and unloading, glass instruments, cosmetics, sales of daily necessities, other business services, other professional consulting, and self-management services; agent services; import and export of various commodities and technologies; and house leasing services. The company is also involved in the import and export of proprietary Chinese medicines, chemical preparations, antibiotics, biochemical drugs, biological preparations, diagnostic drugs, therapeutic and diagnostic biological products, stereotyped packaged foods, chemical products, and self-management and agency of various commodities and technologies. In addition, it engages in the retail and distribution of medical devices, as well as wholesale and retail of health supplies, etc. The company was formerly known as Shenzhen Health Mineral Water Corp., Ltd. The company was incorporated in 1993 and is headquartered in Shenzhen, China. China National Accord Medicines Corporation Ltd. operates as a subsidiary of Sinopharm Group Co., Ltd.

Fundamental data was last updated by Penke on 2024-04-13 15:24:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is inefficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is just able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is underpriced.
Based on how much money comes from the company's main activities, the company is cheap.

1.1. Profitability of China National Accord Medicines Corp Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit China National Accord Medicines Corp Ltd earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare China National Accord Medicines Corp Ltd to the Medical Distribution industry mean.
  • A Net Profit Margin of 2.2% means that ¥0.02 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of China National Accord Medicines Corp Ltd:

  • The MRQ is 2.2%. The company is making a profit. +1
  • The TTM is 2.1%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ2.2%TTM2.1%+0.1%
TTM2.1%YOY2.0%+0.1%
TTM2.1%5Y2.2%-0.1%
5Y2.2%10Y2.5%-0.3%
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ2.2%2.1%+0.1%
TTM2.1%2.0%+0.1%
YOY2.0%2.5%-0.5%
5Y2.2%2.2%0.0%
10Y2.5%2.3%+0.2%
1.1.2. Return on Assets

Shows how efficient China National Accord Medicines Corp Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare China National Accord Medicines Corp Ltd to the Medical Distribution industry mean.
  • 0.9% Return on Assets means that China National Accord Medicines Corp Ltd generated ¥0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of China National Accord Medicines Corp Ltd:

  • The MRQ is 0.9%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is 0.8%. Using its assets, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ0.9%TTM0.8%+0.0%
TTM0.8%YOY0.8%0.0%
TTM0.8%5Y0.9%0.0%
5Y0.9%10Y1.1%-0.3%
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9%1.6%-0.7%
TTM0.8%1.6%-0.8%
YOY0.8%1.2%-0.4%
5Y0.9%1.0%-0.1%
10Y1.1%1.4%-0.3%
1.1.3. Return on Equity

Shows how efficient China National Accord Medicines Corp Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare China National Accord Medicines Corp Ltd to the Medical Distribution industry mean.
  • 2.4% Return on Equity means China National Accord Medicines Corp Ltd generated ¥0.02 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of China National Accord Medicines Corp Ltd:

  • The MRQ is 2.4%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 2.4%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ2.4%TTM2.4%0.0%
TTM2.4%YOY2.4%0.0%
TTM2.4%5Y2.4%-0.1%
5Y2.4%10Y3.0%-0.5%
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ2.4%3.7%-1.3%
TTM2.4%3.1%-0.7%
YOY2.4%2.8%-0.4%
5Y2.4%2.5%-0.1%
10Y3.0%3.2%-0.2%

1.2. Operating Efficiency of China National Accord Medicines Corp Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient China National Accord Medicines Corp Ltd is operating .

  • Measures how much profit China National Accord Medicines Corp Ltd makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare China National Accord Medicines Corp Ltd to the Medical Distribution industry mean.
  • An Operating Margin of 0.0% means the company generated ¥0.00  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of China National Accord Medicines Corp Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM1.6%-1.6%
TTM1.6%YOY3.1%-1.5%
TTM1.6%5Y3.0%-1.5%
5Y3.0%10Y1.8%+1.3%
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.9%-2.9%
TTM1.6%2.8%-1.2%
YOY3.1%3.9%-0.8%
5Y3.0%3.5%-0.5%
10Y1.8%3.4%-1.6%
1.2.2. Operating Ratio

Measures how efficient China National Accord Medicines Corp Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Distribution industry mean).
  • An Operation Ratio of 1.83 means that the operating costs are ¥1.83 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of China National Accord Medicines Corp Ltd:

  • The MRQ is 1.829. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.847. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.829TTM1.847-0.018
TTM1.847YOY1.846+0.001
TTM1.8475Y1.850-0.003
5Y1.85010Y1.448+0.401
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ1.8291.642+0.187
TTM1.8471.594+0.253
YOY1.8461.431+0.415
5Y1.8501.365+0.485
10Y1.4481.229+0.219

1.3. Liquidity of China National Accord Medicines Corp Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if China National Accord Medicines Corp Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Distribution industry mean).
  • A Current Ratio of 1.49 means the company has ¥1.49 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of China National Accord Medicines Corp Ltd:

  • The MRQ is 1.494. The company is just able to pay all its short-term debts.
  • The TTM is 1.435. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.494TTM1.435+0.059
TTM1.435YOY1.424+0.011
TTM1.4355Y1.452-0.017
5Y1.45210Y0.847+0.606
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ1.4941.389+0.105
TTM1.4351.400+0.035
YOY1.4241.424+0.000
5Y1.4521.411+0.041
10Y0.8471.329-0.482
1.3.2. Quick Ratio

Measures if China National Accord Medicines Corp Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare China National Accord Medicines Corp Ltd to the Medical Distribution industry mean.
  • A Quick Ratio of 0.75 means the company can pay off ¥0.75 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of China National Accord Medicines Corp Ltd:

  • The MRQ is 0.746. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.816. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.746TTM0.816-0.069
TTM0.816YOY0.820-0.004
TTM0.8165Y0.784+0.032
5Y0.78410Y0.850-0.066
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7460.730+0.016
TTM0.8160.745+0.071
YOY0.8200.798+0.022
5Y0.7840.7840.000
10Y0.8500.850+0.000

1.4. Solvency of China National Accord Medicines Corp Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of China National Accord Medicines Corp Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare China National Accord Medicines Corp Ltd to Medical Distribution industry mean.
  • A Debt to Asset Ratio of 0.56 means that China National Accord Medicines Corp Ltd assets are financed with 55.9% credit (debt) and the remaining percentage (100% - 55.9%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of China National Accord Medicines Corp Ltd:

  • The MRQ is 0.559. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.584. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.559TTM0.584-0.025
TTM0.584YOY0.583+0.001
TTM0.5845Y0.580+0.004
5Y0.58010Y0.585-0.005
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5590.610-0.051
TTM0.5840.606-0.022
YOY0.5830.600-0.017
5Y0.5800.580+0.000
10Y0.5850.592-0.007
1.4.2. Debt to Equity Ratio

Measures if China National Accord Medicines Corp Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare China National Accord Medicines Corp Ltd to the Medical Distribution industry mean.
  • A Debt to Equity ratio of 152.7% means that company has ¥1.53 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of China National Accord Medicines Corp Ltd:

  • The MRQ is 1.527. The company is just able to pay all its debts with equity.
  • The TTM is 1.700. The company is just able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ1.527TTM1.700-0.173
TTM1.700YOY1.697+0.004
TTM1.7005Y1.675+0.026
5Y1.67510Y1.599+0.076
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ1.5271.554-0.027
TTM1.7001.554+0.146
YOY1.6971.688+0.009
5Y1.6751.6750.000
10Y1.5991.760-0.161

2. Market Valuation of China National Accord Medicines Corp Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings China National Accord Medicines Corp Ltd generates.

  • Above 15 is considered overpriced but always compare China National Accord Medicines Corp Ltd to the Medical Distribution industry mean.
  • A PE ratio of 9.85 means the investor is paying ¥9.85 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of China National Accord Medicines Corp Ltd:

  • The EOD is 11.964. Based on the earnings, the company is underpriced. +1
  • The MRQ is 9.848. Based on the earnings, the company is underpriced. +1
  • The TTM is 12.043. Based on the earnings, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD11.964MRQ9.848+2.116
MRQ9.848TTM12.043-2.195
TTM12.043YOY10.910+1.133
TTM12.0435Y14.058-2.015
5Y14.05810Y22.989-8.930
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
EOD11.96412.350-0.386
MRQ9.84814.424-4.576
TTM12.04315.740-3.697
YOY10.91018.720-7.810
5Y14.05815.472-1.414
10Y22.98919.379+3.610
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of China National Accord Medicines Corp Ltd:

  • The EOD is 3.567. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 2.936. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 0.854. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD3.567MRQ2.936+0.631
MRQ2.936TTM0.854+2.082
TTM0.854YOY0.640+0.214
TTM0.8545Y2.246-1.392
5Y2.24610Y8.355-6.108
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
EOD3.5676.479-2.912
MRQ2.9366.758-3.822
TTM0.8547.751-6.897
YOY0.6400.886-0.246
5Y2.2462.246+0.000
10Y8.3551.985+6.370
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of China National Accord Medicines Corp Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Distribution industry mean).
  • A PB ratio of 0.77 means the investor is paying ¥0.77 for each ¥1 in book value.

Let's take a look of the Price to Book Ratio trends of China National Accord Medicines Corp Ltd:

  • The EOD is 0.934. Based on the equity, the company is cheap. +2
  • The MRQ is 0.769. Based on the equity, the company is cheap. +2
  • The TTM is 1.018. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD0.934MRQ0.769+0.165
MRQ0.769TTM1.018-0.249
TTM1.018YOY0.816+0.202
TTM1.0185Y1.139-0.121
5Y1.13910Y2.708-1.569
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
EOD0.9340.962-0.028
MRQ0.7691.157-0.388
TTM1.0181.157-0.139
YOY0.8161.208-0.392
5Y1.1391.257-0.118
10Y2.7081.922+0.786
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of China National Accord Medicines Corp Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.920-0.596+165%0.733+26%0.452+104%0.823+12%
Book Value Per Share--37.69236.575+3%38.766-3%35.143+7%25.444+48%
Current Ratio--1.4941.435+4%1.424+5%1.452+3%0.847+76%
Debt To Asset Ratio--0.5590.584-4%0.583-4%0.580-4%0.585-4%
Debt To Equity Ratio--1.5271.700-10%1.697-10%1.675-9%1.599-5%
Dividend Per Share--0.0080.409-98%0.454-98%0.343-98%0.305-97%
Eps--0.7360.766-4%0.766-4%0.720+2%0.611+20%
Free Cash Flow Per Share--2.4681.175+110%1.153+114%0.903+173%1.001+146%
Free Cash Flow To Equity Per Share--2.468-0.289+112%0.376+556%-0.027+101%0.614+302%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--240.783--------
Intrinsic Value_10Y_min--65.011--------
Intrinsic Value_1Y_max--6.928--------
Intrinsic Value_1Y_min--4.444--------
Intrinsic Value_3Y_max--33.925--------
Intrinsic Value_3Y_min--15.225--------
Intrinsic Value_5Y_max--76.726--------
Intrinsic Value_5Y_min--27.976--------
Market Cap17089237643.520+6%16134821582.23020641621207.364-22%15336402010.720+5%19589431106.445-18%24217340694.381-33%
Net Profit Margin--0.0220.021+3%0.020+8%0.0220%0.025-13%
Operating Margin---0.016-100%0.031-100%0.030-100%0.018-100%
Operating Ratio--1.8291.847-1%1.846-1%1.850-1%1.448+26%
Pb Ratio0.934+18%0.7691.018-24%0.816-6%1.139-32%2.708-72%
Pe Ratio11.964+18%9.84812.043-18%10.910-10%14.058-30%22.989-57%
Price Per Share35.220+18%28.99037.088-22%31.608-8%39.282-26%49.365-41%
Price To Free Cash Flow Ratio3.567+18%2.9360.854+244%0.640+358%2.246+31%8.355-65%
Price To Total Gains Ratio37.960+18%31.24624.274+29%29.862+5%37.394-16%57.503-46%
Quick Ratio--0.7460.816-9%0.820-9%0.784-5%0.850-12%
Return On Assets--0.0090.008+6%0.008+4%0.009+1%0.011-22%
Return On Equity--0.0240.024-1%0.024-1%0.024-4%0.030-21%
Total Gains Per Share--0.928-0.187+120%1.187-22%0.794+17%1.128-18%
Usd Book Value--2899137554.3902813227715.998+3%2599497401.510+12%2428718737.375+19%1742283931.521+66%
Usd Book Value Change Per Share--0.127-0.082+165%0.101+26%0.062+104%0.114+12%
Usd Book Value Per Share--5.2095.055+3%5.357-3%4.857+7%3.516+48%
Usd Dividend Per Share--0.0010.057-98%0.063-98%0.047-98%0.042-97%
Usd Eps--0.1020.106-4%0.106-4%0.099+2%0.084+20%
Usd Free Cash Flow--189860891.23890345846.460+110%77331111.068+146%62894979.874+202%56562782.594+236%
Usd Free Cash Flow Per Share--0.3410.162+110%0.159+114%0.125+173%0.138+146%
Usd Free Cash Flow To Equity Per Share--0.341-0.040+112%0.052+556%-0.004+101%0.085+302%
Usd Market Cap2361732642.334+6%2229832342.6642852672050.858-22%2119490757.882+5%2707259378.911-18%3346836483.963-33%
Usd Price Per Share4.867+18%4.0065.125-22%4.368-8%5.429-26%6.822-41%
Usd Profit--56605630.69455254286.354+2%51365749.386+10%49030408.990+15%41345192.762+37%
Usd Revenue--2610821905.8192607747093.632+0%2537460382.940+3%2273207923.820+15%1743287267.062+50%
Usd Total Gains Per Share--0.128-0.026+120%0.164-22%0.110+17%0.156-18%
 EOD+4 -4MRQTTM+24 -11YOY+22 -135Y+24 -1110Y+21 -14

3.2. Fundamental Score

Let's check the fundamental score of China National Accord Medicines Corp Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1511.964
Price to Book Ratio (EOD)Between0-10.934
Net Profit Margin (MRQ)Greater than00.022
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.746
Current Ratio (MRQ)Greater than11.494
Debt to Asset Ratio (MRQ)Less than10.559
Debt to Equity Ratio (MRQ)Less than11.527
Return on Equity (MRQ)Greater than0.150.024
Return on Assets (MRQ)Greater than0.050.009
Total5/10 (50.0%)

3.3. Technical Score

Let's check the technical score of China National Accord Medicines Corp Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5073.324
Ma 20Greater thanMa 5031.446
Ma 50Greater thanMa 10031.283
Ma 100Greater thanMa 20030.188
OpenGreater thanClose34.000
Total3/5 (60.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets47,571,095
Total Liabilities26,593,254
Total Stockholder Equity17,414,809
 As reported
Total Liabilities 26,593,254
Total Stockholder Equity+ 17,414,809
Total Assets = 47,571,095

Assets

Total Assets47,571,095
Total Current Assets36,370,055
Long-term Assets11,201,040
Total Current Assets
Cash And Cash Equivalents 6,502,348
Net Receivables 18,160,331
Inventory 7,989,001
Other Current Assets 214,624
Total Current Assets  (as reported)36,370,055
Total Current Assets  (calculated)32,866,304
+/- 3,503,750
Long-term Assets
Property Plant Equipment 3,724,435
Goodwill 2,746,684
Intangible Assets 615,588
Long-term Assets Other 307,855
Long-term Assets  (as reported)11,201,040
Long-term Assets  (calculated)7,394,562
+/- 3,806,478

Liabilities & Shareholders' Equity

Total Current Liabilities24,338,224
Long-term Liabilities2,255,030
Total Stockholder Equity17,414,809
Total Current Liabilities
Short Long Term Debt 2,612,674
Accounts payable 17,952,052
Other Current Liabilities 81,679
Total Current Liabilities  (as reported)24,338,224
Total Current Liabilities  (calculated)20,646,406
+/- 3,691,818
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt1,451,788
Long-term Liabilities Other 575,309
Long-term Liabilities  (as reported)2,255,030
Long-term Liabilities  (calculated)2,027,097
+/- 227,934
Total Stockholder Equity
Retained Earnings 12,311,521
Total Stockholder Equity (as reported)17,414,809
Total Stockholder Equity (calculated)12,311,521
+/- 5,103,288
Other
Capital Stock556,565
Common Stock Shares Outstanding 556,565
Net Invested Capital 20,027,483
Net Working Capital 12,031,830
Property Plant and Equipment Gross 3,724,435



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-06-302000-12-312000-06-30
> Total Assets 
571,830
490,887
1,175,445
1,118,169
1,097,132
1,085,078
1,152,476
1,052,597
1,106,858
1,184,718
1,005,604
1,008,327
972,124
876,922
930,409
846,187
850,510
962,296
950,185
1,072,448
2,186,568
2,378,400
2,473,769
2,679,240
2,762,903
2,871,416
3,032,615
2,906,088
3,139,532
3,464,408
3,678,531
3,683,974
4,273,372
4,502,174
5,012,705
5,233,489
5,515,056
5,741,019
6,105,680
6,306,793
6,547,314
6,968,070
7,323,930
7,665,760
8,069,832
8,662,233
9,050,107
9,295,840
9,675,832
10,120,888
10,586,761
11,057,897
12,270,543
12,490,102
12,966,920
12,828,942
13,399,262
13,812,657
14,298,938
13,218,350
14,172,329
14,485,587
14,962,097
21,312,755
21,519,366
22,199,775
23,155,827
22,343,644
23,760,906
24,013,016
28,244,710
28,930,301
30,855,285
33,539,599
34,816,993
33,520,609
36,882,641
37,669,850
42,013,201
39,594,533
43,020,753
44,190,878
44,855,600
42,783,682
44,844,103
45,968,981
47,461,838
42,615,761
47,885,198
49,882,939
50,736,935
47,571,095
47,571,09550,736,93549,882,93947,885,19842,615,76147,461,83845,968,98144,844,10342,783,68244,855,60044,190,87843,020,75339,594,53342,013,20137,669,85036,882,64133,520,60934,816,99333,539,59930,855,28528,930,30128,244,71024,013,01623,760,90622,343,64423,155,82722,199,77521,519,36621,312,75514,962,09714,485,58714,172,32913,218,35014,298,93813,812,65713,399,26212,828,94212,966,92012,490,10212,270,54311,057,89710,586,76110,120,8889,675,8329,295,8409,050,1078,662,2338,069,8327,665,7607,323,9306,968,0706,547,3146,306,7936,105,6805,741,0195,515,0565,233,4895,012,7054,502,1744,273,3723,683,9743,678,5313,464,4083,139,5322,906,0883,032,6152,871,4162,762,9032,679,2402,473,7692,378,4002,186,5681,072,448950,185962,296850,510846,187930,409876,922972,1241,008,3271,005,6041,184,7181,106,8581,052,5971,152,4761,085,0781,097,1321,118,1691,175,445490,887571,830
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
19,899,359
24,005,143
24,495,616
26,350,683
27,020,030
28,268,585
26,652,455
28,544,825
29,392,091
31,948,728
29,262,092
32,237,296
33,205,980
33,672,640
31,848,416
33,786,109
34,967,495
36,519,799
31,708,246
36,929,434
38,840,028
39,698,249
36,370,055
36,370,05539,698,24938,840,02836,929,43431,708,24636,519,79934,967,49533,786,10931,848,41633,672,64033,205,98032,237,29629,262,09231,948,72829,392,09128,544,82526,652,45528,268,58527,020,03026,350,68324,495,61624,005,14319,899,359000000000000000000000000000000000000000000000000000000000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,943,596
6,983,235
8,089,781
7,227,934
8,086,329
7,810,811
8,882,335
7,343,919
8,239,840
6,962,649
5,998,204
5,840,136
5,876,638
5,030,550
5,126,159
4,867,545
5,573,558
5,985,764
6,016,350
5,946,206
5,699,788
5,187,888
6,502,348
6,502,3485,187,8885,699,7885,946,2066,016,3505,985,7645,573,5584,867,5455,126,1595,030,5505,876,6385,840,1365,998,2046,962,6498,239,8407,343,9198,882,3357,810,8118,086,3297,227,9348,089,7816,983,2353,943,596000000000000000000000000000000000000000000000000000000000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
278,456
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000278,45600000000000000000000000000000000000000000000000000000000000000000000000
       Net Receivables 
84,115
73,395
373,330
345,183
365,803
349,931
354,173
348,749
398,876
407,427
382,876
373,510
391,278
404,038
431,885
349,312
369,216
388,550
424,785
392,026
1,055,354
1,137,734
1,216,342
1,377,911
1,453,959
1,559,466
1,615,790
1,486,464
1,685,694
1,868,340
2,000,500
1,981,194
2,184,893
2,482,887
2,776,126
2,854,394
2,957,305
3,227,111
3,400,459
3,279,105
3,525,887
3,712,526
4,214,356
4,134,818
4,774,760
5,052,624
5,375,746
5,077,171
5,551,960
6,007,197
6,286,967
6,444,341
6,472,363
7,093,943
7,724,621
7,647,880
8,381,087
8,448,478
8,789,063
6,984,721
8,390,026
8,313,082
8,750,678
9,480,205
10,801,938
10,507,753
11,132,636
9,590,050
11,775,758
11,253,536
11,868,403
11,141,084
11,592,127
11,826,441
13,181,036
12,062,425
14,414,273
15,389,464
17,916,394
16,067,356
18,464,514
19,488,317
20,215,950
18,104,119
20,241,570
20,985,527
21,656,753
16,306,349
19,303,106
23,940,114
25,359,580
18,160,331
18,160,33125,359,58023,940,11419,303,10616,306,34921,656,75320,985,52720,241,57018,104,11920,215,95019,488,31718,464,51416,067,35617,916,39415,389,46414,414,27312,062,42513,181,03611,826,44111,592,12711,141,08411,868,40311,253,53611,775,7589,590,05011,132,63610,507,75310,801,9389,480,2058,750,6788,313,0828,390,0266,984,7218,789,0638,448,4788,381,0877,647,8807,724,6217,093,9436,472,3636,444,3416,286,9676,007,1975,551,9605,077,1715,375,7465,052,6244,774,7604,134,8184,214,3563,712,5263,525,8873,279,1053,400,4593,227,1112,957,3052,854,3942,776,1262,482,8872,184,8931,981,1942,000,5001,868,3401,685,6941,486,4641,615,7901,559,4661,453,9591,377,9111,216,3421,137,7341,055,354392,026424,785388,550369,216349,312431,885404,038391,278373,510382,876407,427398,876348,749354,173349,931365,803345,183373,33073,39584,115
       Other Current Assets 
2,864
1,397
19,438
48,495
48,667
43,827
61,488
67,139
62,260
44,484
12,752
5,782
7,732
10,322
11,287
11,696
16,915
18,445
31,804
25,015
28,692
24,558
38,442
33,167
56,615
51,172
67,068
54,123
54,951
36,629
69,161
40,035
32,737
39,673
65,812
85,647
113,760
100,402
125,933
101,806
97,245
81,612
121,834
72,737
116,528
62,138
86,987
97,593
99,035
71,448
71,670
76,571
85,764
131,407
125,347
142,484
124,217
126,761
118,067
101,209
72,139
63,164
69,923
442,359
442,688
405,648
478,154
531,104
498,907
456,873
513,812
596,959
78,539
97,317
69,262
760,270
879,985
417,880
597,645
624,391
713,586
621,366
694,848
701,646
618,429
503,224
581,667
1,549,574
130,912
684,992
667,004
214,624
214,624667,004684,992130,9121,549,574581,667503,224618,429701,646694,848621,366713,586624,391597,645417,880879,985760,27069,26297,31778,539596,959513,812456,873498,907531,104478,154405,648442,688442,35969,92363,16472,139101,209118,067126,761124,217142,484125,347131,40785,76476,57171,67071,44899,03597,59386,98762,138116,52872,737121,83481,61297,245101,806125,933100,402113,76085,64765,81239,67332,73740,03569,16136,62954,95154,12367,06851,17256,61533,16738,44224,55828,69225,01531,80418,44516,91511,69611,28710,3227,7325,78212,75244,48462,26067,13961,48843,82748,66748,49519,4381,3972,864
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,504,601
6,519,569
6,548,408
6,868,154
8,337,816
8,277,759
10,064,473
10,332,441
10,783,457
10,984,898
11,182,959
10,935,267
11,057,994
11,001,486
10,942,040
10,907,514
10,955,764
11,042,911
11,038,686
11,201,040
11,201,04011,038,68611,042,91110,955,76410,907,51410,942,04011,001,48611,057,99410,935,26711,182,95910,984,89810,783,45710,332,44110,064,4738,277,7598,337,8166,868,1546,548,4086,519,5694,504,601000000000000000000000000000000000000000000000000000000000000000000000000
       Property Plant Equipment 
212,913
167,496
178,457
180,703
179,666
191,170
208,174
166,008
163,312
183,418
180,240
191,525
188,058
181,911
179,044
177,647
175,776
174,839
178,595
198,112
357,045
396,534
419,959
440,145
377,214
453,861
419,519
399,435
344,799
401,193
368,125
447,911
470,332
521,402
444,726
545,980
466,693
577,806
520,576
705,598
606,017
742,849
664,941
841,239
709,609
843,753
726,682
908,504
793,942
904,710
830,063
1,005,040
880,211
937,845
977,099
1,075,777
1,084,309
1,112,081
1,138,707
1,255,509
1,240,286
1,103,075
1,094,987
534,074
556,700
554,013
559,035
574,658
581,857
580,908
596,186
644,346
622,792
2,536,514
2,479,741
2,599,644
2,795,724
2,817,999
3,228,366
3,257,775
3,303,287
3,428,897
3,526,058
3,493,716
3,549,440
3,498,510
3,437,128
3,407,099
3,428,267
3,547,394
3,575,632
3,724,435
3,724,4353,575,6323,547,3943,428,2673,407,0993,437,1283,498,5103,549,4403,493,7163,526,0583,428,8973,303,2873,257,7753,228,3662,817,9992,795,7242,599,6442,479,7412,536,514622,792644,346596,186580,908581,857574,658559,035554,013556,700534,0741,094,9871,103,0751,240,2861,255,5091,138,7071,112,0811,084,3091,075,777977,099937,845880,2111,005,040830,063904,710793,942908,504726,682843,753709,609841,239664,941742,849606,017705,598520,576577,806466,693545,980444,726521,402470,332447,911368,125401,193344,799399,435419,519453,861377,214440,145419,959396,534357,045198,112178,595174,839175,776177,647179,044181,911188,058191,525180,240183,418163,312166,008208,174191,170179,666180,703178,457167,496212,913
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
85,229
85,229
85,229
79,379
79,379
79,379
79,379
79,379
79,379
51,359
51,359
823,890
827,955
827,963
826,039
830,729
830,729
830,729
830,729
833,548
833,548
847,042
871,042
944,080
1,513,176
1,564,932
2,746,548
2,747,375
2,975,269
2,932,001
2,932,001
2,775,646
2,775,646
2,775,646
2,775,646
2,749,910
2,749,910
2,746,684
2,746,684
2,746,684
2,746,6842,746,6842,746,6842,749,9102,749,9102,775,6462,775,6462,775,6462,775,6462,932,0012,932,0012,975,2692,747,3752,746,5481,564,9321,513,176944,080871,042847,042833,548833,548830,729830,729830,729830,729826,039827,963827,955823,89051,35951,35979,37979,37979,37979,37979,37979,37985,22985,22985,2290000000000000000000000000000000000000000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,770,421
1,936,600
2,034,080
2,118,718
2,231,497
2,261,376
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000002,261,3762,231,4972,118,7182,034,0801,936,6001,770,421000000000000000000000000000000000000000000000000000000000000000000000
       Intangible Assets 
94,533
86,951
3,954
3,669
4,255
3,400
3,348
3,129
3,068
7,016
2,933
3,062
3,142
2,815
11,110
2,216
2,026
1,853
1,616
1,557
1,890
2,867
3,027
2,469
31,549
6,999
30,960
2,035
54,445
3,908
54,601
3,323
144,390
38,623
138,383
35,179
141,497
28,700
173,989
24,436
173,451
17,993
174,437
9,062
172,710
33,416
230,916
41,094
244,622
39,785
241,709
38,869
234,006
232,736
230,891
223,763
222,656
220,588
219,232
217,099
216,239
169,892
167,655
1,144,326
1,146,496
1,161,962
1,156,078
1,156,481
1,153,651
314,817
310,687
319,207
325,673
286,803
314,252
319,947
635,391
608,062
748,672
734,345
722,393
751,493
738,313
669,927
678,355
681,603
671,484
647,516
649,760
645,451
628,895
615,588
615,588628,895645,451649,760647,516671,484681,603678,355669,927738,313751,493722,393734,345748,672608,062635,391319,947314,252286,803325,673319,207310,687314,8171,153,6511,156,4811,156,0781,161,9621,146,4961,144,326167,655169,892216,239217,099219,232220,588222,656223,763230,891232,736234,00638,869241,70939,785244,62241,094230,91633,416172,7109,062174,43717,993173,45124,436173,98928,700141,49735,179138,38338,623144,3903,32354,6013,90854,4452,03530,9606,99931,5492,4693,0272,8671,8901,5571,6161,8532,0262,21611,1102,8153,1423,0622,9337,0163,0683,1293,3483,4004,2553,6693,95486,95194,533
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
214,362
206,945
73,829
77,355
414,121
333,986
1,137,051
408,198
472,896
484,260
471,819
459,986
466,226
474,990
507,983
436,871
415,226
390,536
355,244
307,855
307,855355,244390,536415,226436,871507,983474,990466,226459,986471,819484,260472,896408,1981,137,051333,986414,12177,35573,829206,945214,362000000000000000000000000000000000000000000000000000000000000000000000000
> Total Liabilities 
113,662
85,827
786,439
753,715
732,292
715,440
781,082
717,900
772,951
849,171
670,653
665,466
626,530
523,967
574,747
487,989
481,302
584,800
564,586
678,727
1,742,896
1,930,274
2,010,412
2,206,339
2,309,558
2,389,178
2,527,029
2,388,511
2,581,803
2,864,465
3,032,276
3,034,604
3,547,012
3,712,804
4,176,212
4,355,358
4,570,583
4,746,002
5,049,332
5,175,348
5,326,910
5,701,647
5,976,570
6,238,959
6,524,621
7,034,990
7,330,133
7,456,789
7,689,555
8,065,742
8,397,082
8,741,260
7,849,699
7,949,973
8,317,900
7,977,726
8,344,455
8,633,887
8,927,901
7,651,875
8,400,856
8,480,801
8,771,256
12,398,771
12,310,877
12,849,528
13,548,839
12,416,141
13,504,130
13,534,392
14,692,327
15,024,524
16,600,496
18,981,102
19,899,115
18,160,771
21,097,566
21,652,042
25,614,423
22,705,906
25,695,351
26,702,750
27,057,334
24,761,470
26,527,298
27,438,825
28,514,797
23,171,054
27,998,280
29,788,760
30,271,046
26,593,254
26,593,25430,271,04629,788,76027,998,28023,171,05428,514,79727,438,82526,527,29824,761,47027,057,33426,702,75025,695,35122,705,90625,614,42321,652,04221,097,56618,160,77119,899,11518,981,10216,600,49615,024,52414,692,32713,534,39213,504,13012,416,14113,548,83912,849,52812,310,87712,398,7718,771,2568,480,8018,400,8567,651,8758,927,9018,633,8878,344,4557,977,7268,317,9007,949,9737,849,6998,741,2608,397,0828,065,7427,689,5557,456,7897,330,1337,034,9906,524,6216,238,9595,976,5705,701,6475,326,9105,175,3485,049,3324,746,0024,570,5834,355,3584,176,2123,712,8043,547,0123,034,6043,032,2762,864,4652,581,8032,388,5112,527,0292,389,1782,309,5582,206,3392,010,4121,930,2741,742,896678,727564,586584,800481,302487,989574,747523,967626,530665,466670,653849,171772,951717,900781,082715,440732,292753,715786,43985,827113,662
   > Total Current Liabilities 
113,661
85,827
776,439
750,345
728,922
712,070
777,712
717,100
772,151
846,372
667,853
662,666
623,729
523,166
573,947
487,189
480,502
584,000
563,786
677,927
1,714,893
1,903,879
1,887,490
2,082,679
2,186,007
2,265,744
2,423,765
2,272,720
2,466,204
2,769,875
2,907,692
2,968,493
3,480,742
3,591,836
4,052,805
4,251,753
4,467,698
4,643,827
4,965,603
5,042,033
5,138,525
5,513,523
5,768,388
6,027,176
6,263,817
6,682,134
7,018,961
7,129,837
7,355,310
7,760,493
8,154,043
8,490,369
7,600,512
7,656,251
7,953,159
7,687,757
8,049,196
8,339,089
8,605,866
7,326,026
8,082,336
8,246,424
8,541,109
12,135,715
12,050,481
12,561,701
13,259,393
12,130,238
13,222,025
13,256,464
14,412,809
14,757,973
16,327,806
17,568,977
18,506,524
16,730,453
19,173,616
19,694,342
23,359,608
20,257,521
23,311,053
24,280,469
24,611,715
22,379,018
24,185,927
25,029,009
26,163,018
21,027,599
25,911,745
27,585,168
28,071,671
24,338,224
24,338,22428,071,67127,585,16825,911,74521,027,59926,163,01825,029,00924,185,92722,379,01824,611,71524,280,46923,311,05320,257,52123,359,60819,694,34219,173,61616,730,45318,506,52417,568,97716,327,80614,757,97314,412,80913,256,46413,222,02512,130,23813,259,39312,561,70112,050,48112,135,7158,541,1098,246,4248,082,3367,326,0268,605,8668,339,0898,049,1967,687,7577,953,1597,656,2517,600,5128,490,3698,154,0437,760,4937,355,3107,129,8377,018,9616,682,1346,263,8176,027,1765,768,3885,513,5235,138,5255,042,0334,965,6034,643,8274,467,6984,251,7534,052,8053,591,8363,480,7422,968,4932,907,6922,769,8752,466,2042,272,7202,423,7652,265,7442,186,0072,082,6791,887,4901,903,8791,714,893677,927563,786584,000480,502487,189573,947523,166623,729662,666667,853846,372772,151717,100777,712712,070728,922750,345776,43985,827113,661
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,966,927
3,290,878
2,417,214
1,453,018
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000001,453,0182,417,2143,290,8782,966,927000000000000000000000000000000000000000000000000000000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,966,927
3,290,878
2,417,214
1,453,018
2,785,254
3,710,647
3,223,873
1,612,187
3,947,852
4,632,934
3,280,898
1,930,467
3,038,581
3,099,021
2,899,753
1,260,515
3,407,475
3,975,743
4,412,600
2,612,674
2,612,6744,412,6003,975,7433,407,4751,260,5152,899,7533,099,0213,038,5811,930,4673,280,8984,632,9343,947,8521,612,1873,223,8733,710,6472,785,2541,453,0182,417,2143,290,8782,966,927000000000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
15,609
7,522
370,937
359,153
331,007
336,213
381,804
306,149
333,174
339,049
233,646
292,063
257,875
229,432
250,346
280,977
266,376
315,242
302,122
376,186
1,006,022
1,224,737
1,364,060
1,376,163
1,497,081
1,530,402
1,698,762
1,549,395
1,617,262
1,870,845
2,131,707
2,148,540
2,317,447
2,510,443
2,866,169
2,806,494
2,913,768
2,975,098
3,292,073
3,452,189
3,336,255
3,460,307
3,641,293
3,549,604
3,643,118
4,154,261
4,363,189
4,302,630
4,448,026
4,766,756
5,054,120
4,932,338
4,933,894
5,455,079
5,766,017
5,457,045
5,420,869
5,715,150
6,069,589
5,338,505
5,903,424
6,113,778
6,356,447
9,108,201
9,094,774
9,562,983
10,303,831
8,876,659
9,778,083
9,603,653
10,511,612
9,885,292
11,051,700
11,627,793
13,234,395
12,109,803
12,354,262
12,769,531
16,709,290
15,217,616
15,572,364
16,422,930
18,096,031
16,717,936
17,369,877
17,720,021
19,105,637
15,232,999
18,047,359
19,382,991
20,103,144
17,952,052
17,952,05220,103,14419,382,99118,047,35915,232,99919,105,63717,720,02117,369,87716,717,93618,096,03116,422,93015,572,36415,217,61616,709,29012,769,53112,354,26212,109,80313,234,39511,627,79311,051,7009,885,29210,511,6129,603,6539,778,0838,876,65910,303,8319,562,9839,094,7749,108,2016,356,4476,113,7785,903,4245,338,5056,069,5895,715,1505,420,8695,457,0455,766,0175,455,0794,933,8944,932,3385,054,1204,766,7564,448,0264,302,6304,363,1894,154,2613,643,1183,549,6043,641,2933,460,3073,336,2553,452,1893,292,0732,975,0982,913,7682,806,4942,866,1692,510,4432,317,4472,148,5402,131,7071,870,8451,617,2621,549,3951,698,7621,530,4021,497,0811,376,1631,364,0601,224,7371,006,022376,186302,122315,242266,376280,977250,346229,432257,875292,063233,646339,049333,174306,149381,804336,213331,007359,153370,9377,52215,609
       Other Current Liabilities 
30,542
25,676
156,686
153,950
152,673
159,815
172,166
238,795
247,965
250,133
214,477
180,251
195,854
206,234
241,101
193,712
201,626
258,758
251,664
291,741
499,071
495,142
461,630
409,530
420,495
434,315
452,062
468,929
419,578
410,530
490,139
383,285
465,105
469,377
337,727
471,069
413,598
427,736
482,870
614,368
551,060
655,118
610,151
613,774
647,488
674,756
639,750
1,068,269
1,020,999
1,069,383
704,555
805,289
744,720
800,370
711,743
712,758
615,662
643,009
613,798
772,627
851,744
788,605
903,175
1,313,151
1,382,074
1,126,766
1,385,914
1,282,260
1,713,769
860,119
1,515,132
991,437
243,324
798,481
623
1,045,733
3,203,684
1,445,784
2,392,531
1,278,587
2,755,763
1,415,224
2,128,722
1,473,512
2,662,434
1,588,781
2,920,372
1,808,652
62,540
1,808,833
2,228,489
81,679
81,6792,228,4891,808,83362,5401,808,6522,920,3721,588,7812,662,4341,473,5122,128,7221,415,2242,755,7631,278,5872,392,5311,445,7843,203,6841,045,733623798,481243,324991,4371,515,132860,1191,713,7691,282,2601,385,9141,126,7661,382,0741,313,151903,175788,605851,744772,627613,798643,009615,662712,758711,743800,370744,720805,289704,5551,069,3831,020,9991,068,269639,750674,756647,488613,774610,151655,118551,060614,368482,870427,736413,598471,069337,727469,377465,105383,285490,139410,530419,578468,929452,062434,315420,495409,530461,630495,142499,071291,741251,664258,758201,626193,712241,101206,234195,854180,251214,477250,133247,965238,795172,166159,815152,673153,950156,68625,67630,542
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
272,690
1,412,126
1,392,591
1,430,318
1,923,950
1,957,700
2,254,815
2,448,385
2,384,298
2,422,282
2,445,618
2,382,452
2,341,372
2,409,816
2,351,779
2,143,455
2,086,535
2,203,592
2,199,375
2,255,030
2,255,0302,199,3752,203,5922,086,5352,143,4552,351,7792,409,8162,341,3722,382,4522,445,6182,422,2822,384,2982,448,3852,254,8151,957,7001,923,9501,430,3181,392,5911,412,126272,690000000000000000000000000000000000000000000000000000000000000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-2,966,927
-2,104,416
-1,251,906
-270,611
1,261,825
1,216,076
1,315,854
1,303,054
1,304,731
1,361,131
1,414,901
1,375,428
1,420,669
1,391,475
1,357,139
1,327,404
1,311,788
1,349,998
1,371,111
1,451,788
1,451,7881,371,1111,349,9981,311,7881,327,4041,357,1391,391,4751,420,6691,375,4281,414,9011,361,1311,304,7311,303,0541,315,8541,216,0761,261,825-270,611-1,251,906-2,104,416-2,966,927000000000000000000000000000000000000000000000000000000000000000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
100,319
1,254,302
68,388
73,257
391,785
472,490
604,195
809,671
744,139
699,503
680,158
671,319
591,913
695,542
713,708
561,102
521,471
605,260
602,743
575,309
575,309602,743605,260521,471561,102713,708695,542591,913671,319680,158699,503744,139809,671604,195472,490391,78573,25768,3881,254,302100,319000000000000000000000000000000000000000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
261,074
266,031
311,329
307,485
311,312
330,156
366,462
359,837
356,074
0
457,705
489,003
523,193
547,555
633,975
621,061
603,906
578,153
0
0
537,611
520,475
0
0520,475537,61100578,153603,906621,061633,975547,555523,193489,003457,7050356,074359,837366,462330,156311,312307,485311,329266,031261,074000000000000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
352,261
322,993
375,921
354,009
354,787
359,925
361,753
333,335
332,465
334,047
333,484
341,584
344,408
351,811
355,035
358,198
369,208
377,495
385,598
393,721
412,699
416,761
440,903
447,732
427,979
458,869
479,205
484,114
522,138
560,977
605,020
627,987
671,057
736,048
783,305
822,666
886,621
915,472
977,656
1,052,370
1,139,630
1,184,759
1,265,860
1,350,218
1,467,647
1,548,400
1,656,701
1,775,943
1,919,759
1,985,025
2,120,961
2,244,758
4,341,642
4,457,763
4,567,637
4,764,608
4,961,634
5,079,401
5,266,154
5,453,394
5,652,383
5,886,726
6,067,416
8,450,151
8,722,716
8,864,455
9,109,326
9,396,572
9,689,304
9,910,259
11,016,213
11,618,433
11,918,582
12,140,440
12,451,751
12,806,411
13,062,640
13,199,983
13,554,152
13,948,323
14,277,162
14,346,870
14,679,446
14,924,938
15,177,184
15,342,295
15,715,861
16,125,890
16,488,091
16,613,532
16,972,948
17,414,809
17,414,80916,972,94816,613,53216,488,09116,125,89015,715,86115,342,29515,177,18414,924,93814,679,44614,346,87014,277,16213,948,32313,554,15213,199,98313,062,64012,806,41112,451,75112,140,44011,918,58211,618,43311,016,2139,910,2599,689,3049,396,5729,109,3268,864,4558,722,7168,450,1516,067,4165,886,7265,652,3835,453,3945,266,1545,079,4014,961,6344,764,6084,567,6374,457,7634,341,6422,244,7582,120,9611,985,0251,919,7591,775,9431,656,7011,548,4001,467,6471,350,2181,265,8601,184,7591,139,6301,052,370977,656915,472886,621822,666783,305736,048671,057627,987605,020560,977522,138484,114479,205458,869427,979447,732440,903416,761412,699393,721385,598377,495369,208358,198355,035351,811344,408341,584333,484334,047332,465333,335361,753359,925354,787354,009375,921322,993352,261
   Common Stock
160,083
288,149
288,149
288,149
288,149
288,149
288,149
288,149
288,149
288,149
288,149
288,149
288,149
288,149
288,149
288,149
288,149
288,149
288,149
288,149
288,149
288,149
288,149
288,149
288,149
288,149
288,149
288,149
288,149
288,149
288,149
288,149
288,149
288,149
288,149
288,149
288,149
288,149
288,149
288,149
288,149
288,149
288,149
288,149
288,149
288,149
288,149
288,149
288,149
288,149
288,149
288,149
362,632
362,632
362,632
362,632
362,632
362,632
362,632
362,632
362,632
362,632
362,632
362,632
428,127
428,127
428,127
428,127
428,127
428,127
428,127
428,127
428,127
428,127
428,127
428,127
428,127
428,127
428,127
428,127
428,127
428,127
428,127
428,127
428,127
428,127
428,127
0
0
556,565
556,565
0
0556,565556,56500428,127428,127428,127428,127428,127428,127428,127428,127428,127428,127428,127428,127428,127428,127428,127428,127428,127428,127428,127428,127428,127428,127428,127362,632362,632362,632362,632362,632362,632362,632362,632362,632362,632362,632362,632288,149288,149288,149288,149288,149288,149288,149288,149288,149288,149288,149288,149288,149288,149288,149288,149288,149288,149288,149288,149288,149288,149288,149288,149288,149288,149288,149288,149288,149288,149288,149288,149288,149288,149288,149288,149288,149288,149288,149288,149288,149288,149288,149288,149288,149288,149288,149288,149288,149288,149288,149160,083
   Retained Earnings 
8,019
0
31,177
7,875
8,653
13,791
15,619
0
2,212
4,989
6,297
13,966
17,517
25,919
30,339
15,554
26,744
34,854
42,921
46,112
69,757
76,376
94,673
96,040
38,365
69,251
89,591
184,071
222,095
260,804
304,863
325,478
368,549
433,565
480,822
511,913
575,868
604,719
666,903
719,209
806,469
851,598
932,699
993,269
1,110,467
1,191,219
1,299,521
1,382,883
1,526,537
1,591,804
1,727,701
1,806,002
2,118,676
2,234,798
2,345,290
2,538,081
2,735,108
2,852,874
3,039,627
3,226,867
3,425,856
3,660,200
3,840,890
4,870,506
5,143,071
5,284,796
5,529,667
5,787,016
6,079,748
6,300,305
6,585,550
6,869,321
6,955,406
7,134,840
7,446,150
7,969,359
8,215,696
8,352,905
8,707,039
9,109,209
9,438,009
9,508,152
9,840,862
10,103,135
10,355,497
10,520,474
10,893,903
11,118,903
11,481,108
11,820,716
12,180,128
12,311,521
12,311,52112,180,12811,820,71611,481,10811,118,90310,893,90310,520,47410,355,49710,103,1359,840,8629,508,1529,438,0099,109,2098,707,0398,352,9058,215,6967,969,3597,446,1507,134,8406,955,4066,869,3216,585,5506,300,3056,079,7485,787,0165,529,6675,284,7965,143,0714,870,5063,840,8903,660,2003,425,8563,226,8673,039,6272,852,8742,735,1082,538,0812,345,2902,234,7982,118,6761,806,0021,727,7011,591,8041,526,5371,382,8831,299,5211,191,2191,110,467993,269932,699851,598806,469719,209666,903604,719575,868511,913480,822433,565368,549325,478304,863260,804222,095184,07189,59169,25138,36596,04094,67376,37669,75746,11242,92134,85426,74415,55430,33925,91917,51713,9666,2974,9892,212015,61913,7918,6537,87531,17708,019
   Capital Surplus 00000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock00000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
26
4,320,985
0
0
45,917
45,910
46,040
46,061
38,483
38,568
38,548
38,592
21,874
21,939
21,870
22,007
0
0
7,903
7,903
0
07,9037,9030022,00721,87021,93921,87438,59238,54838,56838,48346,06146,04045,91045,917004,320,9852600000000000000000000000000000000000000000000000000000000000000000000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue75,477,485
Cost of Revenue-66,425,426
Gross Profit9,052,0599,052,059
 
Operating Income (+$)
Gross Profit9,052,059
Operating Expense-72,978,125
Operating Income2,499,360-63,926,066
 
Operating Expense (+$)
Research Development26,821
Selling General Administrative5,515,067
Selling And Marketing Expenses0
Operating Expense72,978,1255,541,888
 
Net Interest Income (+$)
Interest Income77,554
Interest Expense-248,381
Other Finance Cost-36,662
Net Interest Income-207,489
 
Pretax Income (+$)
Operating Income2,499,360
Net Interest Income-207,489
Other Non-Operating Income Expenses0
Income Before Tax (EBT)2,473,2272,499,360
EBIT - interestExpense = -248,381
1,599,256
1,847,637
Interest Expense248,381
Earnings Before Interest and Taxes (EBIT)02,721,608
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax2,473,227
Tax Provision-514,739
Net Income From Continuing Ops1,958,4871,958,487
Net Income1,599,256
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0207,489
 

Technical Analysis of China National Accord Medicines Corp Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of China National Accord Medicines Corp Ltd. The general trend of China National Accord Medicines Corp Ltd is BULLISH with 42.9% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine China National Accord Medicines Corp Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (42.9%) Bearish trend (-42.9%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of China National Accord Medicines Corp Ltd.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 35.85 < 40.11 < 43.64.

The bearish price targets are: 35.21 > 33.20 > 32.60.

Tweet this
China National Accord Medicines Corp Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of China National Accord Medicines Corp Ltd. The current mas is .

The long score for the Moving Averages is 10/14.
The longshort score for the Moving Averages is 6/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

China National Accord Medicines Corp Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of China National Accord Medicines Corp Ltd. The current macd is 0.82515479.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the China National Accord Medicines Corp Ltd price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for China National Accord Medicines Corp Ltd. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the China National Accord Medicines Corp Ltd price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
China National Accord Medicines Corp Ltd Daily Moving Average Convergence/Divergence (MACD) ChartChina National Accord Medicines Corp Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of China National Accord Medicines Corp Ltd. The current adx is 21.34.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy China National Accord Medicines Corp Ltd shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
China National Accord Medicines Corp Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of China National Accord Medicines Corp Ltd. The current sar is 31.39.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
China National Accord Medicines Corp Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of China National Accord Medicines Corp Ltd. The current rsi is 73.32. The current phase is Overbought in bull market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is 0/(-13 +13).

  • Overbought in bull market: Short-term excessive buying, potential for pullback. Consider taking profits, be cautious of potential correction. -1
  • Trending up: The RSI is trending up. +1
China National Accord Medicines Corp Ltd Daily Relative Strength Index (RSI) ChartChina National Accord Medicines Corp Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of China National Accord Medicines Corp Ltd. The current phase is Overbought in bull market.

The long score for the Stochastic Oscillator is 6/6.
The longshort score for the Stochastic Oscillator is 6/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the China National Accord Medicines Corp Ltd price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
China National Accord Medicines Corp Ltd Daily Stochastic Oscillator ChartChina National Accord Medicines Corp Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of China National Accord Medicines Corp Ltd. The current cci is 204.71.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
China National Accord Medicines Corp Ltd Daily Commodity Channel Index (CCI) ChartChina National Accord Medicines Corp Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of China National Accord Medicines Corp Ltd. The current cmo is 60.59.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
China National Accord Medicines Corp Ltd Daily Chande Momentum Oscillator (CMO) ChartChina National Accord Medicines Corp Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of China National Accord Medicines Corp Ltd. The current willr is -3.59066427.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
China National Accord Medicines Corp Ltd Daily Williams %R ChartChina National Accord Medicines Corp Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of China National Accord Medicines Corp Ltd.

China National Accord Medicines Corp Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of China National Accord Medicines Corp Ltd. The current atr is 1.07492739.

China National Accord Medicines Corp Ltd Daily Average True Range (ATR) ChartChina National Accord Medicines Corp Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of China National Accord Medicines Corp Ltd. The current obv is 215,723,087.

China National Accord Medicines Corp Ltd Daily On-Balance Volume (OBV) ChartChina National Accord Medicines Corp Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of China National Accord Medicines Corp Ltd. The current mfi is 85.28.

The long score for the Money Flow Index (MFI) is 2/2.
The longshort score for the Money Flow Index (MFI) is 2/(-2 +2).

  • MFI > 50: +1
  • MFI > 80: +1
China National Accord Medicines Corp Ltd Daily Money Flow Index (MFI) ChartChina National Accord Medicines Corp Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for China National Accord Medicines Corp Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-23STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-24WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-27STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-28SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2023-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-07STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-13DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-12-14STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-22SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-12-26CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-12-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-29STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-02CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-03BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-10MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-17DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-19WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-22BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-23RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-30MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-02DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-02-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-06DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-07SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-20STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-01MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-07CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-08STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-13SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-18CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-20DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-03-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-09DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-11CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-12CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-15STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-17ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-04-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-19STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

China National Accord Medicines Corp Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of China National Accord Medicines Corp Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5073.324
Ma 20Greater thanMa 5031.446
Ma 50Greater thanMa 10031.283
Ma 100Greater thanMa 20030.188
OpenGreater thanClose34.000
Total3/5 (60.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of China National Accord Medicines Corp Ltd with someone you think should read this too:
  • Are you bullish or bearish on China National Accord Medicines Corp Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about China National Accord Medicines Corp Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about China National Accord Medicines Corp Ltd

I send you an email if I find something interesting about China National Accord Medicines Corp Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about China National Accord Medicines Corp Ltd.

Receive notifications about China National Accord Medicines Corp Ltd in your mailbox!